Author Archives: James

Jobs: Research Fellow, Victoria

Research Fellow

Turning Point Alcohol and Drugs
Temporary Full TimeResearch Fellow
Population Health Research
Turning Point Alcohol and Drug Centre

Population Health Research at Turning Point Alcohol and Drug Centre is looking for a Research Fellow to join the team, and undertake complex research examining alcohol-related harms at a population level.

This person will be responsible for undertaking quantitative research across projects, with support from senior researchers. The successful applicant will be required to undertake complex quantitative
analysis, and to contribute substantially to a range of other research tasks including ethics committee submissions, literature reviews, and the drafting of scientific articles, reports, and publications.

The successful applicant will bring:

• Tertiary qualifications in any relevant field
• Well developed quantitative research skills
• Strong organisational and planning skills
• Experience in research, preferably in health
• Capacity to work as part of a team and autonomously
• An interest in building a career in health research

Applicants are advised to include a written response to the key selection
criteria identified in the position description available at www.easternhealth.org.au.

Enquiries to be directed to Dr Belinda Lloyd, email to belindal@turningpoint.org.au or Sharon Matthews, (03) 9412 9959 or email to sharonm@turningpoint.org.au

Applications Close: 16/11/2012

Dual Diagnosis Screening Video

A suite of training videos demonstrating screening for co-occurring mental health-substance use concerns has now been posted athttp://www.youtube.com/user/DualDiagnosisANZ

 

Developed by Greg Logan with the Victorian Dual Diagnosis Initiative the videos demonstrate the use of the

  • ASSIST screening tool to screen for problematic substance use.
  • K10 screening tool  to gain an indication of a client’s level of psychological distress
  • Modified Mini screening tool to assess a client’s need for further assessment in regard to any mood, anxiety or psychotic disorder
  • PsyCheck screening tool to detect a client’s mental health symptoms
  • Sensitive questioning to detect any co-occurring mental health concerns

Benzodiazepine Support Group – Victoria

From the Victorian APSU:

In recognition of the increasing addiction to benzodiazepines, and the insufficient available support for people struggling with such addiction, as well as with the difficult and long withdrawal, we are establishing the Peer Support Group for Benzos.

The aim of this group is to provide an additional support to people who are going through benzo withdrawal, but it does not replace professional treatment.

The Peer Support Group for Benzos will meet fortnightly at SHARC – 140 Grange Road, Carnegie starting from Friday 12 October at 3pm.

 

The flyer with the further information is available at http://www.apsuonline.org.au/wp-content/uploads/2012/09/flyer.pdf.

 

Drug and Alcohol Issues in Fremantle – Consultation

Dr John Herron, Chairman of the Australian National Council on Drugs (ANCD)  extends an invitation to people working within the alcohol and other drugs sector to attend a:

Consultation on Drug and Alcohol Issues in Fremantle on:

Tuesday 30 October

9:00 – 11.15am

(Arrival tea and coffee from 8.30am, morning tea provided at 10.45am)

To be held at The Esplanade Hotel

Cnr Marine Terrace and Essex Street
Fremantle, WA

 

The ANCD is seeking views from non-government, community based, government, education, health and law enforcement staff on alcohol and other drugs issues in Western Australia.

 

This is your chance to have your voice heard on issues that are important to you, your organisations and your community. The forum aims to be a collage of opinions, ideas and resolutions across a range of areas. The conclusions from the forum will be reported in the ANCD Communiqué which is sent to a number of key decision makers and stakeholders and placed on the ANCD website.

 

The Australian National Council on Drugs is the principal advisory body to Government on drug policy and plays a critical role in ensuring the voice of the community is heard in relation to drug related policies and strategies.

Please feel free to forward this invitation to other relevant people.

 

RSVP by Monday 22 October 2012

Tel: (02) 6166 9600    Fax: (02) 6162 2611    Email: ancd@ancd.org.au

Drug Trends Conference

2012 National Drug Trends Conference

National Maritime Museum, Darling Harbour, Sydney

8.00am – 4.00pm

Tuesday 9th October 2011

Drugs, crime and the front line: Australasian Perspective

 

The National Drug Trends Conference will present recent findings in illicit drug use, markets and related harms across Australia. Convened by Australia’s largest drug monitoring systems, the Illicit Drug Reporting System (IDRS) and the Ecstasy and Related Drugs Reporting System (EDRS), the one day conference will include the first release of the 2012 findings.

We are also delighted to announce that there will be presentations from a number of distinguished international and national guest speakers, including Dr Chris Wilkins (SHORE, Massey University, NZ), Dr Malcolm Dobbin (Dept of Health, VIC), Dr Marianne Jauncey (MSIC), Dr Alex Wodak (St Vincents Hospital), Mr Peter Bowron (Toxicology Unit, Macquarie Hospital), Dr David Bright (UNSW), Ms Claire Rickards (NSW Police), Ms Annie Madden (AIVL), Dr Raimondo Bruno (UTAS), and Ms Amanda Roxburgh (NDARC).

 

Please visit the Conference website (link below) for the full event agenda.

 

Registration

To register please see the conference website http://www.cvent.com/events/national-drug-trends-conference-2012/invitation-ee34d144a427422d943081a00893db7b.aspx

Registration Cost

Conference costs
Registration $250
Student $200
Cancellation fee $80

The IDRS and EDRS are funded by the Australian Government Department of Health and Ageing.

 

We look forward to seeing you in Sydney!

Further Support for Australia21 report

Families and Friends for Drug Law Reform congratulates and welcomes the second report from
Australia21 entitled “Alternatives to prohibition – Illicit drugs: How we can stop killing and
criminalising young Australians”.

“Australia21 is one of the few organisations that has had the courage to speak publicly on the
grave consequences that is visited on young people and their families because of  our prohibition
drug laws,” said Brian McConnell, President of Families and Friends for Drug Law Reform.
“Prohibition has been an experiment that has failed. Even though the United Nations recognised
this in 1988, it and the rest of the world persisted, thinking that if they tried even harder it might
just work. ”

In its 1988 convention on drugs the UN, among other things, said that it was “Deeply concerned
also by the steadily increasing inroads into various social groups made by illicit traffic in
narcotic drugs and psychotropic substances, and particularly by the fact that children are used in
many parts of the world as an illicit drug consumers market and for purposes of illicit production,
distribution and trade in narcotic drugs and psychotropic substances, which entails a danger of
incalculable gravity.”

And yet it continued with the same failed policies with no evaluation and it even believed that it
could achieve a drug free world by 2008.

“Australia21 has examined the prohibition policy and has identified some of the possible options
for consideration. In short Australia21 has thrown the gauntlet down and challenged Australian
governments to discuss the alternatives,” said McConnell.

“It is telling that Australia21 has focused on the fact that the drug laws are killing our young
people as this report is released just one day after the 20th anniversary of the overdose death of
my oldest son. If the use of drugs had not been driven underground by the prohibition laws and if
it had been treated just as a health problem, we would not have been in the dark about his drug use
and we might have been able to save his life.”

The report examines the measures being taken in respect of drugs in a number of countries. It
looks favourably on the Swiss prescription heroin scheme, the Dutch cannabis model and the
Portuguese decriminalisation approach. The Swiss scheme has clearly been effective and it was
just such a scheme that was proposed in 1997 in Australia, and approved by all health and justice
ministers, but because of pressure by the USA, was vetoed by John Howard. Many young lives
have been lost because of that decision.

The Portuguese decriminalised all drugs for personal use in 2001 with mostly positive results .
Lisa Prior, journalist, writer and medical student, has said in the report “one of the things I like
about the Portuguese system is that I would feel more confident of dobbing drug addicted kids in
to the police, confident that the outcome would help rather than [the alternative] jail.”

“I, also would be more confident,” said McConnell. “But it would be for the reason that drug use
would not be hidden and driven underground, but would be more open, where young people
would be more likely to discuss their problems with their parents and seek help early.”
Families and Friends for Drug Law Reform urges all governments to seriously consider this report
from the independent organisation Australia21.

“I personally urge parents who have been affected in the same way that my family has to speak
out, to overcome the shame and stigma heaped on them by the current laws, and take this
opportunity to save the lives of our young people,” said McConnell.

Support For Australian Drug Law Reform (ADCA & PHAA)

Health groups support new report urging drug law reform in Australia

Two of Australia’s leading public health advocacy groups have expressed their unwavering support for the latest Australia 21 report, Alternatives to Prohibition.

The report follows the release in April of the inaugural report The Prohibition of Illicit Drugs is Killing and Criminalising our Children and we are all letting it happen and its finding that the “war on drugs” had failed. Today’s  considers the experience in several European countries where emphasis has shifted from drug law enforcement to health and social intervention.

The Public Health Association of Australia (PHAA) and the Alcohol and other Drugs Council of Australia (ADCA), the peak AOD body representing Australia’s non-government sector, unreservedly back the intent of the new report. They say the exploration of alternatives to enforcement in the Netherlands, Switzerland, Portugal and Sweden had resulted in many positives.

The overseas experience is that drug policy reform which increases the emphasis on health and social intervention can reduce deaths, disease and crime.

PHAA Acting CEO Melanie Walker said, “Former Prime Minister Rudd hit the nail on the head when he observed that Australia spends only around one percent of the health budget on prevention but 70 times that amount treating people when they get sick. There are similar comparisons with the amount spent on public health drug programs which is hugely outweighed by funds poured into law enforcement.

ADCA patron Professor Ian Webster says that Australia needs to take a far more enlightened view. “Our Government must look at what is happening with drug policy developments overseas and be prepared to confront the issues at home.”

“This new report focuses on growing expert opinion, evidence and experience, presenting a compelling case for drug law reform. The fact is that some of these drugs are important to the provision of good medical care in Australia, notably in the management of acute and chronic pain.

“The contribution that many eminent Australians have made to the Alternatives to Prohibition report is based on this understanding, opinions that can no longer be ignored.”

Melanie Walker says that all levels of the community must be aware that decriminalisation doesn’t mean legalisation. “No public health advocate condones drug use but when experts in the field – many of whom contributed to the Australia 21 report – say decriminalisation should be part of a regime to address the illicit drug problem, it’s time governments listened.

“We can’t go on ignoring the cost to society of drugs, not just illicit drugs but also alcohol and tobacco. And no one of these should be considered in isolation from the others.”

ADCA CEO David Templeman says the new report heightens the need for debate at all levels on the decriminalisation of drugs.

“Advocacy groups were disappointed by the Prime Minister’s and Attorney General’s earlier response to the original Australia 21 report in April. The weight of broader community opinion and evidence warrants far more reasoned consideration by decision-makers on all sides of politics.

“The Commonwealth needs to show leadership on this issue. The new report cites the European experience that reducing the emphasis on drug law enforcement doesn’t appear to increase drug use. The past in Europe – and here in Australia – highlights the failure of drug law enforcement efforts alone to reduce drug use.

“Senior law enforcement figures, including former AFP Commissioner Mick Palmer and politicians from across the spectrum have observed that the war on drugs is an unmitigated failure. Thirty years and countless billions have been devoted to it … to what avail?”

The advocacy groups say over-reliance on drug law enforcement doesn’t align with the intent of Australia’s National Drug Strategy (NDS).

Of the three pillars of the NDS – demand, supply and harm reduction – it is reasonable to say the funding emphasis is currently on law enforcement and reduction of supply. Such emphasis leads to an imbalance and over-reliance on policing effort that has typified the “war on drugs” for the past three decades, an imbalance that has seen public health programs poorly funded in comparison.

It’s time for a new approach.

 

Jobs: Service Coordinator – Methadone to Abstinence Residential Service, NSW

WHOS (We Help Ourselves)

Service Coordinator – Methadone to Abstinence Residential Service

 

WHOS operates a Therapeutic Community residential treatment of opioid dependence withdrawal program WHOS MTAR,

for individuals seeking reduction and withdrawal from their opioid substitution treatment (OST).

 

We are looking for an experienced, enthusiastic and motivated person to provide service coordination for the range of WHOS OST

withdrawal residential services under the direction of the manager.

 

The role includes team leadership, service coordination and case management duties, routine activity reports in relation to established KPIs,

and assisting the manager in the carrying out of the aims and objectives of the service.

 

Essential Criteria

  • Recognised qualification in AOD and Mental Health or equivalent degree
  • Sound knowledge of harm reduction strategies
  • Sound knowledge of opioid substitution treatment
  • Demonstrated experience in mental health work
  • A current NSW drivers licence, Current 1st Aid certificate
  • Computer literacy and word processing skills

 

Desirable:

  • Minimum 3 years experience in the AOD field with expertise in assessment, referral, group work and case management
  • Experience working in a therapeutic community

 

 

Remuneration under the Social, Community, Home Care and Disability Services Industry Award 2010.

 

An application package can be obtained from: WHOS MTAR Manager, Lyn Roberts (02) 85-727-461 or by email request to mtmgr@whos.com.au

 

Applications close: 24th September, 2012

Jobs: AOD Counsellor, Victoria

Experienced AOD Counsellor (forensic and voluntary)

Two positions: 12 month contract

Odyssey House offers a range of treatment options to individuals affected by substance use.

 

Two Positions are available with the Odyssey Community Services. Both positions will provide therapeutic interventions to individuals affected by substance use many of whom have co-occurring mental health conditions.

 

  • One position will operate within the Kildonan Stronger Families (SF) team.  The position will also provide secondary consultation and advice to the Stronger Families team. This is a new position to trial an integrated service delivery model to clients referred from child protection services. The work is expected to be outreach with a client load of 4-6 at any one time.  (.6 EFT)
  • The other position provides Counseling Consultancy and Continuing Care (CCCC) to adults referred through ACSO or who are voluntary. This role is located with Odyssey Community services (1.0 EFT).

 

We are seeking applicants interested in either one of these roles or in job sharing arrangements, for example, a full time position incorporating the role at Kildonan and part of the CCCC’s role. Please note that the role located at Kildonan cannot be divided.

 

The ideal candidates will have relevant qualifications (as outlined in the position description), along with experience working with clients from diverse backgrounds and complex AOD presentations.  We are seeking experienced professionals in providing high standard therapeutic interventions, assessment, treatment planning, report writing, and a capacity to work collaboratively with others.

Please refer to the position descriptions for details:

  • AOD CCCC Clinician and Advanced AOD Clinician (Kildonan/Odyssey)

 

¾     Attractive salary package, dependent upon position and experience.

¾       Odyssey House Victoria provides ongoing professional development and clinical supervision.

¾       Applications must address the key selection criteria in covering letter; include a CV and provide two referees.

¾       Applications should be made on line and a position description is available at www.odyssey.org.au/jobs

¾       For more information contact Miranda Manning, Manager Community Service Programs (03) 9420 7610.

Closing date for applications is17th September, 5pm.

More info on anthrax and injecting drug use

Fatal anthrax case in England confirmed

 The Health Protection Agency (HPA) has confirmed that an injecting drug user with an anthrax infection has died in hospital in Blackpool. The case is the eighth to be identified since June, with one in Scotland (DDN, August, page 4), three in Germany, two in Denmark and one in France. The HPA says it remains ‘unclear’ whether the UK cases are

linked to those on mainland Europe but in all instances the source is presumed to be contaminated heroin. The cases are the first among injecting drug users since the Scottish outbreak of 2009-10, which was the largest UK ‘common source’ anthrax outbreak in humans for half a century (DDN, January, page 6). Before that, only one case of a drug user infected with anthrax had ever been reported, in Norway in 2000. A rapid risk assessment by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Centre for Disease Prevention and Control (ECDC) concluded that heroin users in Europe remain at risk of anthrax exposure, and that ‘it is possible’ that the batch of contaminated heroin has the same source as that of the 2009 Scottish outbreak. ‘It’s likely that further cases in people who inject drugs (PWID) will be identified as part of the ongoing outbreak in EU countries,’ said HPA expert in zoonotic infections, Dr Dilys Morgan. ‘The Department of Health has alerted the NHS of the possibility of PWID presenting to emergency departments and walk-in clinics, with symptoms suggestive of anthrax. Anthrax can be cured with antibiotics, if treatment is started early. It is therefore important for medical professionals to know the signs and symptoms to look for, so that there are no delays in providing the necessary treatment.’